Loading…
Differences in Utilization of Drug-Eluting Stents by Race and Payer
Numerous disparities in access to health care by race and gender have been identified in the literature. This study examines differences in the use of drug-eluting stents (DES) versus bare-metal stents (BMS) by race, payer, and income level. Data from New York State’s Percutaneous Coronary Intervent...
Saved in:
Published in: | The American journal of cardiology 2007-10, Vol.100 (8), p.1192-1198 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863 |
---|---|
cites | cdi_FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863 |
container_end_page | 1198 |
container_issue | 8 |
container_start_page | 1192 |
container_title | The American journal of cardiology |
container_volume | 100 |
creator | Hannan, Edward L., PhD Racz, Michael, PhD Walford, Gary, MD Clark, Luther T., MD Holmes, David R., MD King, Spencer B., MD Sharma, Samin, MD |
description | Numerous disparities in access to health care by race and gender have been identified in the literature. This study examines differences in the use of drug-eluting stents (DES) versus bare-metal stents (BMS) by race, payer, and income level. Data from New York State’s Percutaneous Coronary Intervention Reporting System from July 2003 to December 2004 were used to examine use of DES (20,165 patients) relative to BMS (4,547 patients) by race, payer, and annual income level, controlling for a variety of patient and hospital characteristics. African-Americans were found to be less likely to receive DES than other races between July 2003 and March 2004 (adjusted odds ratio [OR] 0.56, 95% confidence interval [CI] 0.50 to 0.65) and between April 2004 and December 2004 (adjusted OR 0.74, 95% CI 0.61 to 0.90). These disparities were reduced (respective adjusted ORs 0.67, 95% CI 0.58 to 0.77 and 0.81, 95% CI 0.66 to 0.91) when controlling for admitting hospital and hospital volume, but were still significant. Medicaid/self-pay patients, and patients living in zip codes with median annual incomes between $20,000 and $30,000 were also less likely to receive DES in the first time period (adjusted respective ORs 0.80, 95% CI 0.68 to 0.93) and 0.85, 95% CI 0.75 to 0.96). In conclusion, African-Americans and low income groups receive DES less frequently than their counterparts compared with BMS. This is related to the hospitals where they are admitted, but not entirely. |
doi_str_mv | 10.1016/j.amjcard.2007.05.039 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68351404</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002914907013215</els_id><sourcerecordid>1361791471</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863</originalsourceid><addsrcrecordid>eNqFklFrFDEQx4Mo9qx-BGUR7NtuJ5tNcnlR5FpboVCx9jnkspOSdS_bJrvC9dOb5RYLffEpBH7zz8wvQ8h7ChUFKk67yuw6a2Jb1QCyAl4BUy_Iiq6lKqmi7CVZAUBdKtqoI_ImpS5fKeXiNTmiUtXAuFiRzZl3DiMGi6nwobgdfe8fzeiHUAyuOIvTXXneT6MPd8XNiGFMxXZf_DQWCxPa4ofZY3xLXjnTJ3y3nMfk9tv5r81leXV98X3z9aq0jeRjWRsuuARmHbXCIRcGRY2KQb0VDFXDpeTOMedMA4YCKmBottJakXm5FuyYnBxy7-PwMGEa9c4ni31vAg5T0mLNOG2gyeDHZ2A3TDHk3nTNgAkpGp4hfoBsHFKK6PR99DsT95qCnhXrTi-K9axYA9dZca77sIRP2x22T1WL0wx8WgCTrOldNMH69MQpKhspZ-7LgcPs7I_HqJP180e0PqIddTv4_7by-VmC7X3w-dHfuMf0b2iqU61B38z7MK8DSKCsppz9BcyfrxE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230367645</pqid></control><display><type>article</type><title>Differences in Utilization of Drug-Eluting Stents by Race and Payer</title><source>Elsevier</source><creator>Hannan, Edward L., PhD ; Racz, Michael, PhD ; Walford, Gary, MD ; Clark, Luther T., MD ; Holmes, David R., MD ; King, Spencer B., MD ; Sharma, Samin, MD</creator><creatorcontrib>Hannan, Edward L., PhD ; Racz, Michael, PhD ; Walford, Gary, MD ; Clark, Luther T., MD ; Holmes, David R., MD ; King, Spencer B., MD ; Sharma, Samin, MD</creatorcontrib><description>Numerous disparities in access to health care by race and gender have been identified in the literature. This study examines differences in the use of drug-eluting stents (DES) versus bare-metal stents (BMS) by race, payer, and income level. Data from New York State’s Percutaneous Coronary Intervention Reporting System from July 2003 to December 2004 were used to examine use of DES (20,165 patients) relative to BMS (4,547 patients) by race, payer, and annual income level, controlling for a variety of patient and hospital characteristics. African-Americans were found to be less likely to receive DES than other races between July 2003 and March 2004 (adjusted odds ratio [OR] 0.56, 95% confidence interval [CI] 0.50 to 0.65) and between April 2004 and December 2004 (adjusted OR 0.74, 95% CI 0.61 to 0.90). These disparities were reduced (respective adjusted ORs 0.67, 95% CI 0.58 to 0.77 and 0.81, 95% CI 0.66 to 0.91) when controlling for admitting hospital and hospital volume, but were still significant. Medicaid/self-pay patients, and patients living in zip codes with median annual incomes between $20,000 and $30,000 were also less likely to receive DES in the first time period (adjusted respective ORs 0.80, 95% CI 0.68 to 0.93) and 0.85, 95% CI 0.75 to 0.96). In conclusion, African-Americans and low income groups receive DES less frequently than their counterparts compared with BMS. This is related to the hospitals where they are admitted, but not entirely.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2007.05.039</identifier><identifier>PMID: 17920356</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject><![CDATA[African Americans ; African Americans - statistics & numerical data ; Aged ; Aged, 80 and over ; Angioplasty, Balloon, Coronary - economics ; Angioplasty, Balloon, Coronary - utilization ; Biological and medical sciences ; Cardiology ; Cardiology. Vascular system ; Cardiovascular ; Cardiovascular disease ; Coronary Stenosis - economics ; Coronary Stenosis - ethnology ; Coronary Stenosis - therapy ; Databases, Factual ; Drug Delivery Systems ; Drug-Eluting Stents - economics ; Drug-Eluting Stents - utilization ; Female ; Health Services Accessibility - economics ; Health Services Accessibility - statistics & numerical data ; Healthcare Disparities ; Hospitalization ; Humans ; Insurance, Health - statistics & numerical data ; Male ; Medicaid - statistics & numerical data ; Medical research ; Medical sciences ; Medicare - statistics & numerical data ; Middle Aged ; Minority Groups - statistics & numerical data ; New York - epidemiology ; Paclitaxel - administration & dosage ; Platelet Aggregation Inhibitors - administration & dosage ; Socioeconomic Factors ; Stents ; United States ; Vulnerable Populations - ethnology ; Vulnerable Populations - statistics & numerical data]]></subject><ispartof>The American journal of cardiology, 2007-10, Vol.100 (8), p.1192-1198</ispartof><rights>Elsevier Inc.</rights><rights>2007 Elsevier Inc.</rights><rights>2007 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. Oct 15, 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863</citedby><cites>FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19174776$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17920356$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hannan, Edward L., PhD</creatorcontrib><creatorcontrib>Racz, Michael, PhD</creatorcontrib><creatorcontrib>Walford, Gary, MD</creatorcontrib><creatorcontrib>Clark, Luther T., MD</creatorcontrib><creatorcontrib>Holmes, David R., MD</creatorcontrib><creatorcontrib>King, Spencer B., MD</creatorcontrib><creatorcontrib>Sharma, Samin, MD</creatorcontrib><title>Differences in Utilization of Drug-Eluting Stents by Race and Payer</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Numerous disparities in access to health care by race and gender have been identified in the literature. This study examines differences in the use of drug-eluting stents (DES) versus bare-metal stents (BMS) by race, payer, and income level. Data from New York State’s Percutaneous Coronary Intervention Reporting System from July 2003 to December 2004 were used to examine use of DES (20,165 patients) relative to BMS (4,547 patients) by race, payer, and annual income level, controlling for a variety of patient and hospital characteristics. African-Americans were found to be less likely to receive DES than other races between July 2003 and March 2004 (adjusted odds ratio [OR] 0.56, 95% confidence interval [CI] 0.50 to 0.65) and between April 2004 and December 2004 (adjusted OR 0.74, 95% CI 0.61 to 0.90). These disparities were reduced (respective adjusted ORs 0.67, 95% CI 0.58 to 0.77 and 0.81, 95% CI 0.66 to 0.91) when controlling for admitting hospital and hospital volume, but were still significant. Medicaid/self-pay patients, and patients living in zip codes with median annual incomes between $20,000 and $30,000 were also less likely to receive DES in the first time period (adjusted respective ORs 0.80, 95% CI 0.68 to 0.93) and 0.85, 95% CI 0.75 to 0.96). In conclusion, African-Americans and low income groups receive DES less frequently than their counterparts compared with BMS. This is related to the hospitals where they are admitted, but not entirely.</description><subject>African Americans</subject><subject>African Americans - statistics & numerical data</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angioplasty, Balloon, Coronary - economics</subject><subject>Angioplasty, Balloon, Coronary - utilization</subject><subject>Biological and medical sciences</subject><subject>Cardiology</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Cardiovascular disease</subject><subject>Coronary Stenosis - economics</subject><subject>Coronary Stenosis - ethnology</subject><subject>Coronary Stenosis - therapy</subject><subject>Databases, Factual</subject><subject>Drug Delivery Systems</subject><subject>Drug-Eluting Stents - economics</subject><subject>Drug-Eluting Stents - utilization</subject><subject>Female</subject><subject>Health Services Accessibility - economics</subject><subject>Health Services Accessibility - statistics & numerical data</subject><subject>Healthcare Disparities</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Insurance, Health - statistics & numerical data</subject><subject>Male</subject><subject>Medicaid - statistics & numerical data</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Medicare - statistics & numerical data</subject><subject>Middle Aged</subject><subject>Minority Groups - statistics & numerical data</subject><subject>New York - epidemiology</subject><subject>Paclitaxel - administration & dosage</subject><subject>Platelet Aggregation Inhibitors - administration & dosage</subject><subject>Socioeconomic Factors</subject><subject>Stents</subject><subject>United States</subject><subject>Vulnerable Populations - ethnology</subject><subject>Vulnerable Populations - statistics & numerical data</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFklFrFDEQx4Mo9qx-BGUR7NtuJ5tNcnlR5FpboVCx9jnkspOSdS_bJrvC9dOb5RYLffEpBH7zz8wvQ8h7ChUFKk67yuw6a2Jb1QCyAl4BUy_Iiq6lKqmi7CVZAUBdKtqoI_ImpS5fKeXiNTmiUtXAuFiRzZl3DiMGi6nwobgdfe8fzeiHUAyuOIvTXXneT6MPd8XNiGFMxXZf_DQWCxPa4ofZY3xLXjnTJ3y3nMfk9tv5r81leXV98X3z9aq0jeRjWRsuuARmHbXCIRcGRY2KQb0VDFXDpeTOMedMA4YCKmBottJakXm5FuyYnBxy7-PwMGEa9c4ni31vAg5T0mLNOG2gyeDHZ2A3TDHk3nTNgAkpGp4hfoBsHFKK6PR99DsT95qCnhXrTi-K9axYA9dZca77sIRP2x22T1WL0wx8WgCTrOldNMH69MQpKhspZ-7LgcPs7I_HqJP180e0PqIddTv4_7by-VmC7X3w-dHfuMf0b2iqU61B38z7MK8DSKCsppz9BcyfrxE</recordid><startdate>20071015</startdate><enddate>20071015</enddate><creator>Hannan, Edward L., PhD</creator><creator>Racz, Michael, PhD</creator><creator>Walford, Gary, MD</creator><creator>Clark, Luther T., MD</creator><creator>Holmes, David R., MD</creator><creator>King, Spencer B., MD</creator><creator>Sharma, Samin, MD</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20071015</creationdate><title>Differences in Utilization of Drug-Eluting Stents by Race and Payer</title><author>Hannan, Edward L., PhD ; Racz, Michael, PhD ; Walford, Gary, MD ; Clark, Luther T., MD ; Holmes, David R., MD ; King, Spencer B., MD ; Sharma, Samin, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>African Americans</topic><topic>African Americans - statistics & numerical data</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angioplasty, Balloon, Coronary - economics</topic><topic>Angioplasty, Balloon, Coronary - utilization</topic><topic>Biological and medical sciences</topic><topic>Cardiology</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Cardiovascular disease</topic><topic>Coronary Stenosis - economics</topic><topic>Coronary Stenosis - ethnology</topic><topic>Coronary Stenosis - therapy</topic><topic>Databases, Factual</topic><topic>Drug Delivery Systems</topic><topic>Drug-Eluting Stents - economics</topic><topic>Drug-Eluting Stents - utilization</topic><topic>Female</topic><topic>Health Services Accessibility - economics</topic><topic>Health Services Accessibility - statistics & numerical data</topic><topic>Healthcare Disparities</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Insurance, Health - statistics & numerical data</topic><topic>Male</topic><topic>Medicaid - statistics & numerical data</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Medicare - statistics & numerical data</topic><topic>Middle Aged</topic><topic>Minority Groups - statistics & numerical data</topic><topic>New York - epidemiology</topic><topic>Paclitaxel - administration & dosage</topic><topic>Platelet Aggregation Inhibitors - administration & dosage</topic><topic>Socioeconomic Factors</topic><topic>Stents</topic><topic>United States</topic><topic>Vulnerable Populations - ethnology</topic><topic>Vulnerable Populations - statistics & numerical data</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hannan, Edward L., PhD</creatorcontrib><creatorcontrib>Racz, Michael, PhD</creatorcontrib><creatorcontrib>Walford, Gary, MD</creatorcontrib><creatorcontrib>Clark, Luther T., MD</creatorcontrib><creatorcontrib>Holmes, David R., MD</creatorcontrib><creatorcontrib>King, Spencer B., MD</creatorcontrib><creatorcontrib>Sharma, Samin, MD</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hannan, Edward L., PhD</au><au>Racz, Michael, PhD</au><au>Walford, Gary, MD</au><au>Clark, Luther T., MD</au><au>Holmes, David R., MD</au><au>King, Spencer B., MD</au><au>Sharma, Samin, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differences in Utilization of Drug-Eluting Stents by Race and Payer</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2007-10-15</date><risdate>2007</risdate><volume>100</volume><issue>8</issue><spage>1192</spage><epage>1198</epage><pages>1192-1198</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Numerous disparities in access to health care by race and gender have been identified in the literature. This study examines differences in the use of drug-eluting stents (DES) versus bare-metal stents (BMS) by race, payer, and income level. Data from New York State’s Percutaneous Coronary Intervention Reporting System from July 2003 to December 2004 were used to examine use of DES (20,165 patients) relative to BMS (4,547 patients) by race, payer, and annual income level, controlling for a variety of patient and hospital characteristics. African-Americans were found to be less likely to receive DES than other races between July 2003 and March 2004 (adjusted odds ratio [OR] 0.56, 95% confidence interval [CI] 0.50 to 0.65) and between April 2004 and December 2004 (adjusted OR 0.74, 95% CI 0.61 to 0.90). These disparities were reduced (respective adjusted ORs 0.67, 95% CI 0.58 to 0.77 and 0.81, 95% CI 0.66 to 0.91) when controlling for admitting hospital and hospital volume, but were still significant. Medicaid/self-pay patients, and patients living in zip codes with median annual incomes between $20,000 and $30,000 were also less likely to receive DES in the first time period (adjusted respective ORs 0.80, 95% CI 0.68 to 0.93) and 0.85, 95% CI 0.75 to 0.96). In conclusion, African-Americans and low income groups receive DES less frequently than their counterparts compared with BMS. This is related to the hospitals where they are admitted, but not entirely.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>17920356</pmid><doi>10.1016/j.amjcard.2007.05.039</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9149 |
ispartof | The American journal of cardiology, 2007-10, Vol.100 (8), p.1192-1198 |
issn | 0002-9149 1879-1913 |
language | eng |
recordid | cdi_proquest_miscellaneous_68351404 |
source | Elsevier |
subjects | African Americans African Americans - statistics & numerical data Aged Aged, 80 and over Angioplasty, Balloon, Coronary - economics Angioplasty, Balloon, Coronary - utilization Biological and medical sciences Cardiology Cardiology. Vascular system Cardiovascular Cardiovascular disease Coronary Stenosis - economics Coronary Stenosis - ethnology Coronary Stenosis - therapy Databases, Factual Drug Delivery Systems Drug-Eluting Stents - economics Drug-Eluting Stents - utilization Female Health Services Accessibility - economics Health Services Accessibility - statistics & numerical data Healthcare Disparities Hospitalization Humans Insurance, Health - statistics & numerical data Male Medicaid - statistics & numerical data Medical research Medical sciences Medicare - statistics & numerical data Middle Aged Minority Groups - statistics & numerical data New York - epidemiology Paclitaxel - administration & dosage Platelet Aggregation Inhibitors - administration & dosage Socioeconomic Factors Stents United States Vulnerable Populations - ethnology Vulnerable Populations - statistics & numerical data |
title | Differences in Utilization of Drug-Eluting Stents by Race and Payer |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A57%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differences%20in%20Utilization%20of%20Drug-Eluting%20Stents%20by%20Race%20and%20Payer&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Hannan,%20Edward%20L.,%20PhD&rft.date=2007-10-15&rft.volume=100&rft.issue=8&rft.spage=1192&rft.epage=1198&rft.pages=1192-1198&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2007.05.039&rft_dat=%3Cproquest_cross%3E1361791471%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c475t-2a565703cf1c6fe56ae62e9302b63e945775ff3ffa40a10e903eab7cc61c67863%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=230367645&rft_id=info:pmid/17920356&rfr_iscdi=true |